Literature DB >> 18349411

Effects of chemoradiation on tumor-host interactions: the immunologic side.

Silvia C Formenti, Sandra Demaria.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349411     DOI: 10.1200/JCO.2007.15.5499

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer.

Authors:  Arianna Barbetta; Tamar B Nobel; Smita Sihag; Meier Hsu; Kay See Tan; Manjit S Bains; James M Isbell; Yelena Y Janjigian; Abraham J Wu; Matthew J Bott; David R Jones; Daniela Molena
Journal:  Ann Thorac Surg       Date:  2018-05-05       Impact factor: 4.330

2.  Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.

Authors:  Silvia C Formenti; Encouse B Golden; Judith D Goldberg; Xiaochun Li; Jessica Taff; Maria B Fenton-Kerimian; Sharanya Chandrasekhar; Sandra Demaria; Yelena Novik
Journal:  Oncoimmunology       Date:  2016-12-27       Impact factor: 8.110

3.  Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival.

Authors:  Sylvia Adams; A Bapsi Chakravarthy; Martin Donach; Darcy Spicer; Stella Lymberis; Baljit Singh; Joshua A Bauer; Tsivia Hochman; Judith D Goldberg; Franco Muggia; Robert J Schneider; Jennifer A Pietenpol; Silvia C Formenti
Journal:  Breast Cancer Res Treat       Date:  2010-09-29       Impact factor: 4.872

4.  Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy.

Authors:  O Kyu Noh; Seung Yeop Oh; Young Bae Kim; Kwang Wook Suh
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

5.  Combined influence of adjuvant therapy and interval after surgery on peripheral CD4(+) T lymphocytes in patients with esophageal squamous cell carcinoma.

Authors:  Yang Ling; Lieying Fan; Chunlei Dong; Jing Zhu; Yongping Liu; Yan Ni; Changtai Zhu; Changsong Zhang
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

Review 6.  Combining radiotherapy and cancer immunotherapy: a paradigm shift.

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  J Natl Cancer Inst       Date:  2013-01-04       Impact factor: 13.506

Review 7.  The implication and potential applications of high-mobility group box 1 protein in breast cancer.

Authors:  Moonindranath Sohun; Huiling Shen
Journal:  Ann Transl Med       Date:  2016-06

8.  The convergence of radiation and immunogenic cell death signaling pathways.

Authors:  Encouse B Golden; Ilenia Pellicciotta; Sandra Demaria; Mary H Barcellos-Hoff; Silvia C Formenti
Journal:  Front Oncol       Date:  2012-08-07       Impact factor: 6.244

Review 9.  Local control by radiotherapy: is that all there is?

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Breast Cancer Res       Date:  2008-11-05       Impact factor: 6.466

10.  CpG plus radiotherapy: a review of preclinical works leading to clinical trial.

Authors:  Kathy A Mason; Nancy R Hunter
Journal:  Front Oncol       Date:  2012-08-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.